AC Immune ACIU
NASDAQ ACIU
$2.81 +0.00 (+0.00%)
As of: Oct 2, 2026 · 9:34 AM EDT

AC Immune (ACIU) Accumulated Expenses (2014 - 2026)

Updated

AC Immune (ACIU) reported Accumulated Expenses of $9.01 million for the quarter ended Jun 30, 2026, down 35.0% from $13.86 million a year earlier but up 9.1% from the prior quarter.

Analysis

AC Immune (ACIU) Accumulated Expenses (2014 - 2026) Analysis & Trends

As of Dec 31, 2025, AC Immune posted Accumulated Expenses of $9.73 million, down 29.2% from the prior year.

  • Accumulated Expenses has a five-year compound annual growth rate of -3.8% (years ended Dec 2020 to Dec 2025).
  • By year, Accumulated Expenses came in at $13.75 million in the year ended Dec 31, 2024 (+11.4%), $12.34 million in the year ended Dec 31, 2023 (+25.1%), $9.87 million in the year ended Dec 31, 2022 (-46.1%) and $18.32 million in the year ended Dec 31, 2021 (+55.0%).
  • Five-year quarterly Accumulated Expenses spans a low of $8.26 million in the quarter ended Mar 31, 2026 and a high of $18.15 million in the quarter ended Dec 31, 2021.
  • Year over year, Accumulated Expenses has now declined in each of the last three quarters, with an average decline of 4.4% over the last eight quarters.
  • The high point for year-over-year Accumulated Expenses in five years was the quarter ended Dec 31, 2021 (growth of 48.0%); the low point was the quarter ended Dec 31, 2022 (a decline of 46.1%).
  • Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $8.26 million (quarter ended Mar 31, 2026), $10.09 million (quarter ended Dec 31, 2025) and $14.99 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 AC Immune 266.56 Mn 266.56 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.01 Mn
Mar 31, 2026 8.26 Mn
Dec 31, 2025 10.09 Mn
Sep 30, 2025 14.99 Mn
Jun 30, 2025 13.86 Mn
Mar 31, 2025 12.40 Mn
Dec 31, 2024 13.81 Mn
Sep 30, 2024 14.89 Mn
Jun 30, 2024 13.15 Mn
Mar 31, 2024 12.08 Mn
Dec 31, 2023 12.50 Mn
Sep 30, 2023 10.57 Mn
Jun 30, 2023 12.35 Mn
Mar 31, 2023 9.36 Mn
Dec 31, 2022 9.78 Mn
Sep 30, 2022 11.37 Mn
Jun 30, 2022 9.76 Mn
Mar 31, 2022 11.45 Mn
Dec 31, 2021 18.15 Mn
Sep 30, 2021 14.49 Mn
API Access

AC Immune Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ACIU&period=max&api_key=YOUR_API_KEY